| http://www.w3.org/ns/prov#value | - The patient's manic symptoms were remitted and maintained on monotherapy with risperidone 6???mg.Cutaneous manifestation is reported in 3.4???45% of patients on lithium in the maintenance phase.[1, 2] The mechanism is considered to be type IV hypersensitivity and associated with decreased cAMP, increased production of neutrophils and keratinocyte proliferation;[1] but lithium is an element found i
|
